Allied Irish, Glaxo, Glencore, Shire: U.K., Irish Equity Preview

The following is a list of companies that may have unusual share-price changes in U.K. and Irish markets. Stock symbols are in parentheses and prices are from the last market close.

The FTSE 100 Index retreated 98.61 points, or 1.7 percent, to 5,674.38 yesterday. The FTSE All-Share Index fell 1.7 percent, while Ireland’s ISEQ Index declined 1.2 percent.

Allied Irish Banks Plc (ALBK) : The Dublin-based bank said the state’s stake is likely to rise “substantially beyond” its current 93 percent level as part of the bank’s capital increase. The stock dived 5.5 percent to 15.6 euro cents.

Bank of Ireland Plc (BKIR LN): Ireland’s largest bank may raise a total of 2.5 billion euros ($3.6 billion) from its offer to swap subordinated debt for equity or cash, according to Glas Securities, the Dublin-based fixed-income firm. The shares plunged 5.4 percent to 12.2 euro cents.

Berkeley Group Holdings Plc (BKG) : The U.K.’s largest homebuilder by market value said annual profit rose 19 percent as the company sold more homes at higher prices. The stock dropped 3 percent to 1,131 pence.

GlaxoSmithKline Plc (GSK) : The attorney generals of 37 U.S. states and the District of Columbia reached a $40.8 million settlement with Glaxo and SB Pharmco Puerto Rico Inc. to resolve allegations they breached drug manufacturing standards. The shares fell 0.7 percent to 1,272.5 pence.

Glencore International Plc (GLEN LN): JPMorgan Chase & Co. rated the world’s largest commodity trader “neutral” in new coverage and set a price estimate for the shares at 550 pence. The stock dropped 4.8 percent to 466.65 pence.

Shire Plc (SHP) : The drugmaker won a U.S. panel’s backing to sell a new treatment for a generic swelling disease that would compete with CSL Ltd.’s Berinert and Dyax Inc. Outside advisers to the Food and Drug Administration voted 12-1 in favor of approval of Shire’s Firazyr for treating acute attacks of hereditary angioedema. The FDA isn’t required to follow their recommendations. The shares rose 0.4 percent to 1,854 pence.

Unilever (ULVR LN): The world’s second-largest consumer- goods company appointed Harish Manwani, its president for Asia and Africa, as chief operating officer to spur growth in emerging markets. The stock dropped 1.7 percent to 1,941 pence.

Vodafone Group Plc (VOD) : Exane BNP Paribas reiterated its “outperform” recommendation for the world’s largest mobile-phone operator, saying the stock’s selloff offers a “good entry point” for investors. The shares slid 0.9 percent to 163 pence.

To contact the reporters on this story: Blanche Gatt in London at bgatt@bloomberg.net; Sarah Jones in London at sjones35@bloomberg.net

To contact the editor responsible for this story: Colin Keatinge at ckeatinge@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.